We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$104M
Cap. Flow %
2.08%
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7 years
Top 10 Avg Time Held Equity + Options
2.9 years
Top 20 Avg Time Held Equity + Options
3.8 years
Avg Time Held Equity only
4.7 years
Top 10 Avg Time Held Equity only
2.9 years
Top 20 Avg Time Held Equity only
3.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.71%
2 Technology 17.21%
3 Healthcare 9.68%
4 Financials 7.2%
5 Communication Services 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BCRX icon
3201
BioCryst Pharmaceuticals
BCRX
$2.05B
$833 ﹤0.01%
93
-43
-32% -$400
2024 Q2
4 quarters
OBE icon
3202
Obsidian Energy
OBE
$765M
$833 ﹤0.01%
150
– –
2022 Q1
13 quarters
RRR icon
3203
Red Rock Resorts
RRR
$2.98B
$832 ﹤0.01%
16
-21
-57% -$959
2022 Q4
10 quarters
SIFY icon
3204
Sify Technologies
SIFY
$851M
$831 ﹤0.01%
181
+147
+432% +$662
2025 Q1
1 quarter
GLNG icon
3205
Golar LNG
GLNG
$4.59B
$824 ﹤0.01%
20
-74
-79% -$2.92K
2024 Q3
3 quarters
NXDR icon
3206
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$1.01B
$823 ﹤0.01%
+496
New +$748
2025 Q2
0 quarters
NBBK icon
3207
NB Bancorp
NBBK
$980M
$822 ﹤0.01%
46
-50
-52% -$844
2024 Q4
2 quarters
INVZ icon
3208
Innoviz Technologies
INVZ
$83.9M
$820 ﹤0.01%
500
– –
2023 Q3
7 quarters
DMXF icon
3209
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.01B
$819 ﹤0.01%
11
– –
2024 Q4
2 quarters
ETD icon
3210
Ethan Allen Interiors
ETD
$513M
$808 ﹤0.01%
+29
New +$783
2025 Q2
0 quarters
RBCAA icon
3211
Republic Bancorp
RBCAA
$1.8B
$804 ﹤0.01%
+11
New +$752
2025 Q2
0 quarters
RVLV icon
3212
Revolve Group
RVLV
$1.65B
$802 ﹤0.01%
40
-15
-27% -$304
2023 Q3
7 quarters
PLPC icon
3213
Preformed Line Products
PLPC
$1.81B
$799 ﹤0.01%
+5
New +$712
2025 Q2
0 quarters
DDLS icon
3214
WisdomTree Dynamic International SmallCap Equity Fund
DDLS
$412M
$790 ﹤0.01%
20
– –
2025 Q1
1 quarter
DXPE icon
3215
DXP Enterprises
DXPE
$2.76B
$789 ﹤0.01%
9
+4
+80% +$333
2024 Q4
2 quarters
AGM icon
3216
Federal Agricultural Mortgage
AGM
$2.24B
$777 ﹤0.01%
4
+2
+100% +$367
2021 Q2
16 quarters
MAX icon
3217
MediaAlpha
MAX
$619M
$777 ﹤0.01%
71
+48
+209% +$463
2024 Q4
2 quarters
LFST icon
3218
Lifestance Health
LFST
$4.7B
$776 ﹤0.01%
150
– –
2022 Q4
10 quarters
ARKO icon
3219
ARKO Corp
ARKO
$461M
$774 ﹤0.01%
183
– –
2024 Q2
4 quarters
CYRX icon
3220
CryoPort
CYRX
$865M
$753 ﹤0.01%
101
– –
2025 Q1
1 quarter
IPI icon
3221
Intrepid Potash
IPI
$434M
$750 ﹤0.01%
21
– –
2025 Q1
1 quarter
KRO icon
3222
KRONOS Worldwide
KRO
$852M
$744 ﹤0.01%
120
-215
-64% -$1.47K
2021 Q3
15 quarters
PLL icon
3223
DELISTED
Piedmont Lithium
PLL
$741 ﹤0.01%
+127
New +$830
2025 Q2
0 quarters
AHR icon
3224
American Healthcare REIT
AHR
$11.6B
$735 ﹤0.01%
20
-115
-85% -$3.82K
2024 Q4
2 quarters
AOUT icon
3225
American Outdoor Brands
AOUT
$224M
$732 ﹤0.01%
70
– –
2023 Q1
9 quarters

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.